© 2016, GENASSIST, Inc.          

By Keith S. Wexler, MBA, Maternal Fetal Medicine, Prenatal Diagnosis and Biotech/ Life Sciences Consultant, GENASSIST, Inc.

Paul Wexler, M.D., F.A.C.O.G., Medical Director, GENASSIST, Inc.

Clinical Professor, Department of OB/GYN, University of Colorado Health Sciences Center

Clinical Professor, Division of Genetics/Dept. of Pediatrics, Univ. of Colorado/The Children’s Hospital

Cystic Fibrosis Disease is a common Ashkenazi Jewish inherited disease with a carrier frequency of (1 in 25) and affects (1 in 2500) pregnancies. Cystic Fibrosis is the most common disease in the Caucasian population with a carrier rate of (1 in 25).

Cystic Fibrosis Disease: Autosomal recessive inheritance (25% if both parents are gene carriers) has been described.

Cystic Fibrosis Disease is characterized by the disruption of endocrine function in the pancreas, intestinal glands, bronchial and sweat glands and susceptibility to lower gastrointestinal problems.

*The Ashkenazi Jewish Screen is available in a variety of Panels:

  • Basic Panel – 3 Diseases
  • Expanded Panel – 8 Diseases
  • Full Panel – 18 Diseases

*The Full Panel is now also part of many Microarray Panels that can test for over 100 diseases.

The Jewish population is the United States as of 2012 was 6,543,820 making up 2.1% of the entire U.S. population (1).

The Ashkenazi Jewish Inherited Disease Panel was created to help screen for specific ethnic inherited diseases. Preconceptional testing is suggested to help identify or rule-out the parents as being carriers.

(1) US Census Bureau, Statistical Abstract of the United States, 2012